These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26449663)

  • 1. Search for familial clustering of multiple myeloma with any cancer.
    Frank C; Fallah M; Chen T; Mai EK; Sundquist J; Försti A; Hemminki K
    Leukemia; 2016 Mar; 30(3):627-32. PubMed ID: 26449663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial associations of male breast cancer with other cancers.
    Zheng G; Yu H; Hemminki A; Försti A; Sundquist K; Hemminki K
    Breast Cancer Res Treat; 2017 Dec; 166(3):897-902. PubMed ID: 28836035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Associations Between Prostate Cancer and Other Cancers.
    Frank C; Sundquist J; Hemminki A; Hemminki K
    Eur Urol; 2017 Feb; 71(2):162-165. PubMed ID: 27498599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial associations of female breast cancer with other cancers.
    Zheng G; Yu H; Hemminki A; Försti A; Sundquist K; Hemminki K
    Int J Cancer; 2017 Dec; 141(11):2253-2259. PubMed ID: 28801919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial plasma cell disorders and associated cancers.
    Lynch HT; Snyder CL; Lynch JF; Thomé S
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):80-1. PubMed ID: 21454197
    [No Abstract]   [Full Text] [Related]  

  • 6. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial transmission of prostate, breast and colorectal cancer in adoptees is related to cancer in biological but not in adoptive parents: a nationwide family study.
    Zöller B; Li X; Sundquist J; Sundquist K
    Eur J Cancer; 2014 Sep; 50(13):2319-27. PubMed ID: 24953336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
    Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
    Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common cancers share familial susceptibility: implications for cancer genetics and counselling.
    Yu H; Frank C; Sundquist J; Hemminki A; Hemminki K
    J Med Genet; 2017 Apr; 54(4):248-253. PubMed ID: 27651446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
    Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
    Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.
    Brandefors L; Kimby E; Lundqvist K; Melin B; Lindh J
    Acta Oncol; 2016; 55(1):91-8. PubMed ID: 26559865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.
    Alley CL; Wang E; Dunphy CH; Gong JZ; Lu CM; Boswell EL; Burchette J; Lagoo AS
    Arch Pathol Lab Med; 2013 Apr; 137(4):503-17. PubMed ID: 23544940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and familial risks in pituitary adenoma and associated tumors.
    Hemminki K; Försti A; Ji J
    Endocr Relat Cancer; 2007 Mar; 14(1):103-9. PubMed ID: 17395979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of other Cancers in Families with Melanoma: Novel Familial Links.
    Frank C; Sundquist J; Hemminki A; Hemminki K
    Sci Rep; 2017 Feb; 7():42601. PubMed ID: 28198461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives.
    Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Nomura AM; Kolonel LN
    Am J Epidemiol; 2004 Apr; 159(8):750-8. PubMed ID: 15051584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
    Altieri A; Bermejo JL; Hemminki K
    Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.